IL154006A0 - Method for treating unstable angina pectoris - Google Patents

Method for treating unstable angina pectoris

Info

Publication number
IL154006A0
IL154006A0 IL15400601A IL15400601A IL154006A0 IL 154006 A0 IL154006 A0 IL 154006A0 IL 15400601 A IL15400601 A IL 15400601A IL 15400601 A IL15400601 A IL 15400601A IL 154006 A0 IL154006 A0 IL 154006A0
Authority
IL
Israel
Prior art keywords
angina pectoris
unstable angina
treating unstable
treating
hypercholesterolaemia
Prior art date
Application number
IL15400601A
Other languages
English (en)
Original Assignee
Zlb Bioplasma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zlb Bioplasma Ag filed Critical Zlb Bioplasma Ag
Publication of IL154006A0 publication Critical patent/IL154006A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Supports For Pipes And Cables (AREA)
  • External Artificial Organs (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15400601A 2000-07-20 2001-07-20 Method for treating unstable angina pectoris IL154006A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035352A DE10035352A1 (de) 2000-07-20 2000-07-20 Verfahren zur Behandlung von instabiler Angina pectoris
PCT/EP2001/008425 WO2002007753A2 (fr) 2000-07-20 2001-07-20 Procede de traitement d'une angine de poitrine instable

Publications (1)

Publication Number Publication Date
IL154006A0 true IL154006A0 (en) 2003-07-31

Family

ID=7649620

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15400601A IL154006A0 (en) 2000-07-20 2001-07-20 Method for treating unstable angina pectoris
IL154006A IL154006A (en) 2000-07-20 2003-01-16 Use of High Concentration Lipoprotein (HDL) Restored to Manufacture Compounds for Vascular Disease for Acute Improvement of Endothelial Activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154006A IL154006A (en) 2000-07-20 2003-01-16 Use of High Concentration Lipoprotein (HDL) Restored to Manufacture Compounds for Vascular Disease for Acute Improvement of Endothelial Activity

Country Status (17)

Country Link
US (1) US7053049B2 (fr)
EP (1) EP1303294B1 (fr)
JP (1) JP4928047B2 (fr)
KR (2) KR100864079B1 (fr)
AT (1) ATE333887T1 (fr)
AU (2) AU8200401A (fr)
CA (1) CA2418238C (fr)
DE (2) DE10035352A1 (fr)
DK (1) DK1303294T3 (fr)
ES (1) ES2266234T3 (fr)
HU (1) HU230151B1 (fr)
IL (2) IL154006A0 (fr)
NO (1) NO329848B1 (fr)
NZ (1) NZ523784A (fr)
PL (1) PL204406B1 (fr)
WO (1) WO2002007753A2 (fr)
ZA (1) ZA200300509B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007000924A1 (fr) * 2005-06-28 2007-01-04 Osaka University Préparation pharmaceutique comprenant une substance susceptible d'inhiber ou de promouvoir l'activité de la progranuline et méthode de criblage pour la recherche d'une substance susceptible d'inhiber ou de promouvoir l'activité de la progranuline
US7956035B2 (en) * 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
CN104487253B (zh) 2012-09-25 2016-05-25 惠普发展公司，有限责任合伙企业 液滴检测
ITMI20131300A1 (it) * 2013-08-01 2015-02-02 Nobil Bio Ricerche Srl Composizione per il riempimento di difetti ossei e parodontali
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
GB2603950A (en) 2021-02-22 2022-08-24 Reckitt & Colman Overseas Hygiene Home Ltd Effervescent germicidal compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
CA1335077C (fr) * 1988-02-08 1995-04-04 Henri Isliker Mode de fabrication d'apolipoproteines a partir du plasma ou de serum humains
EP0543417A1 (fr) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotriènols et composés sembles à tocotriènol et méthodes pour leur utilisation
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JPH10218861A (ja) * 1997-02-04 1998-08-18 Yamanouchi Pharmaceut Co Ltd 新規なフェネタノール誘導体又はその塩
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
GB9919713D0 (en) 1999-08-19 1999-10-20 Queen Mary & Westfield College New medical use of high density lipoprotein
AU777788B2 (en) * 1999-11-26 2004-10-28 Heart Research Institute Limited, The Oxidized apolipoproteins and methods of use
AUPQ429399A0 (en) * 1999-11-26 1999-12-23 Heart Research Institute, The Oxidized apolipoproteins and methods of use

Also Published As

Publication number Publication date
EP1303294B1 (fr) 2006-07-26
NO329848B1 (no) 2011-01-10
DE10035352A1 (de) 2002-01-31
KR20030026980A (ko) 2003-04-03
DE50110552D1 (de) 2006-09-07
IL154006A (en) 2010-05-31
WO2002007753A3 (fr) 2003-02-13
WO2002007753A2 (fr) 2002-01-31
PL366395A1 (en) 2005-01-24
AU8200401A (en) 2002-02-05
DK1303294T3 (da) 2006-10-30
CA2418238C (fr) 2012-06-05
HUP0300730A2 (hu) 2003-12-29
HUP0300730A3 (en) 2010-07-28
KR20070108955A (ko) 2007-11-13
EP1303294A2 (fr) 2003-04-23
KR100864079B1 (ko) 2008-10-16
HU230151B1 (hu) 2015-09-28
CA2418238A1 (fr) 2003-01-16
ATE333887T1 (de) 2006-08-15
NZ523784A (en) 2004-06-25
JP4928047B2 (ja) 2012-05-09
AU2001282004B2 (en) 2006-02-02
US20040014654A1 (en) 2004-01-22
PL204406B1 (pl) 2010-01-29
US7053049B2 (en) 2006-05-30
ZA200300509B (en) 2004-02-17
NO20030137L (no) 2003-01-10
ES2266234T3 (es) 2007-03-01
NO20030137D0 (no) 2003-01-10
JP2004504355A (ja) 2004-02-12

Similar Documents

Publication Publication Date Title
NO20034056D0 (no) Proliferative sykdommer
AP2003002890A0 (en) Therapeutic combinations for cardiovascular and inflammatory indications.
BR9913564A (pt) Tratamento de angiopatias microvasculares
HK1064950A1 (en) Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
MXPA05012755A (es) Nitrooxiderivados de fluvastatina, pravastatina, cerivastatina, atorvastatina y rosuvastatina como agentes reductores del colesterol con mejor actividad anti-inflamatoria, anti-trombotica y anti-plaquetaria.
WO2003026643A3 (fr) Methodes et combinaisons therapeutiques utiles pour le traitement du xanthome effectue avec des inhibiteurs d'absorption du sterol
IL153359A0 (en) Peptides, compositions and methods for the treatment of burkholderia cepacia
MXPA03004517A (es) Metodos que emplean y composiciones que contienen fosfolipidos oxidados definidos para la prevencion y tratamiento de la arteriosclerosis.
AU8200401A (en) Method for treating unstable angina pectoris
WO2002039994A3 (fr) Methodes de traitement et de prevention des calculs urinaires
SE9603725D0 (sv) New teatment
WO2002005848A3 (fr) Utilisation d'inhibiteurs de cox-2 pour le traitement et la prevention de troubles oculaires a mediation cox-2
WO2004009029A3 (fr) Compositions et procedes de traitement et de prevention d'infections
EP1303300A4 (fr) Compositions et procedes de traitement de la candidiase
WO2002083700A3 (fr) Disaccharides hypersulfates et leur utilisation en traitement contre les inflammations
AU2001291308A1 (en) Methods and compositions for treating nail fungus
AU2001262378A1 (en) Method for treating cryptorchidism
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x
WO2001062792A3 (fr) Traitement et prevision du cancer
LT2002131A (en) New use of fir oil for cosmetic
AU2001281747A1 (en) Composition and method for the treatment or prevention of hiv infection
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA32651C2 (uk) Спосіб напіввідкритої лапаростомії

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: CSL BEHRING AG

Free format text: FORMER NAME:ZLB BEHRING AG